Acute lymphoblastic leukemia with treatment--naive Fanconi anemia.

Indian Pediatr

Department of Pediatrics, Armed Forces Medical College, Pune, Maharashtra, India 411040.

Published: May 2013

Fanconi anemia is known to have a predisposition to cancer, mostly associated with acute myeloid leukemia. We report an eight year old girl with treatment and naive FA who developed acute lymphoblastic leukemia. She was initiated on chemotherapy but she failed to respond to treatment and died during induction phase of chemotherapy. While this association may be coincidental but possibility of transition of Fanconi anemia to ALL should be considered in view of high predisposition to cancer in this disorder.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fanconi anemia
12
acute lymphoblastic
8
lymphoblastic leukemia
8
predisposition cancer
8
leukemia treatment--naive
4
treatment--naive fanconi
4
anemia fanconi
4
anemia predisposition
4
cancer associated
4
associated acute
4

Similar Publications

: Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.

Haematologica

January 2025

Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva; Sackler Faculty of Medicine, Aviv University, Aviv; ; Pediatric Hematology Laboratory, Felsenstein Medical Research Center, Petach Tikva.

View Article and Find Full Text PDF

ALDH Enzymes and Hematological Diseases: A Scoping Review of Literature.

Discov Med

December 2024

Department of Biological Hematology, Tours University Hospital, 37000 Tours, France.

Aldehyde dehydrogenases (ALDHs) constitute a group of enzymes that catalyze the oxidation of aldehydes to carboxylic acids. The human ALDH superfamily, including 19 different isoenzymes (ALDH1A1, ALDH1A2, ALDH1A3, AHDH1B1, ALDH1L1, ALDH1L2, ALDH2, ALDH3A1, ALDH3A2, ALDH3B1, ALDH3B2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDH8A1, ALDH9A1, ALDHA16A1, ALDH18A1), displays different key physiological and toxicological functions, with specific tissue expression and substrate specificity. Several studies have established that ALDH are interesting markers for the identification and quantification of human hematopoietic stem cells and cancer stem cells, notably leukemic stem cells.

View Article and Find Full Text PDF

Breast cancer stem cells (BCSCs) are a rare cell population that is responsible for tumour initiation, metastasis and chemoresistance. Despite this, the mechanism by which BCSCs withstand genotoxic stress is largely unknown. Here, we uncover a pivotal role for the arginine methyltransferase PRMT5 in mediating BCSC chemoresistance by modulating DNA repair efficiency.

View Article and Find Full Text PDF

Assessments of breast cancer (BC) risk in carriers of pathogenic variants identified by gene panel testing in different populations are highly in demand worldwide. We performed target sequencing of 78 genes involved in DNA repair in 860 females with BC and 520 age- and family history-matched controls from Central Russia. Among BC patients, 562/860 (65.

View Article and Find Full Text PDF

DNA phenotyping and mapping intragenic deletion mutations in Fanconi anemia: Patterns and diagnostic inferences.

J Genet Eng Biotechnol

December 2024

Medical Molecular Genetics Dpt., Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt. Electronic address:

Background: Fanconi anemia is a genetically heterogeneous recessive disorder distinguished by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and disturbed DNA repair. To date, Fanconi anemia complementation group (FANC) includes 23 FANC genes identified of which, FANCA gene is the most commonly mutated. The mutation spectrum of the FANCA gene is highly heterogeneous with large intragenic deletions due to Alu elements-mediated recombination.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!